pharma · Patency of the Ductus Arteriosus · Atopic Dermatitis · CNTB
S.L
S.L is a pharma organization headquartered in SAN DIEGO, CA, EU. It trades on NYSE under ticker CNTB. Primary therapeutic focus areas include Patency of the Ductus Arteriosus, Atopic Dermatitis, Chronic Rhinosinusitis Wi
SAN DIEGO, CA, EU HQ
Public company Type
CNTB · NYSE Ticker
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, EU
- Programs
- 15
- Drugs
- 11
- Patents
- 179
Acetaminophen
Phase 3 · small molecule · Patency of the Ductus Arteriosus
Acetaminophen for Patency of the Ductus Arteriosus is a Phase 3 program (small_molecule) at S.L with 1 ClinicalTrials.gov record(s).
Internal code C19-29
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- S.L
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Patency of the Ductus Arteriosus
- Status
- completed
- Trials
- 1